Medicare Enrolled
Dr. Barry Berman, M.D.
Medical Oncology · West Palm Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Berman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Berman
Dr. Barry Berman is a medical oncology specialist in West Palm Beach, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Berman performed 72,225 Medicare services across 2,824 unique beneficiaries.
Between the years covered by Open Payments, Dr. Berman received a total of $27,923 from 100 pharmaceutical and/or device companies across 995 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Berman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 31% volume in FL
$27,923 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 56669 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗72,225
Medicare services
Top 31% in FL for medical oncology
2,824
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,611 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 12,240 | $0 | $4 |
| Iron sucrose injection (Venofer) | 12,100 | $0 | $5 |
| Contrast dye for imaging (iodine-based) | 10,420 | $0 | $1 |
| Filgrastim injection (Zarxio) for white blood cells | 8,580 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 5,850 | $1 | $5 |
| Epoetin alfa injection (Procrit) for anemia | 5,460 | $6 | $23 |
| Immune globulin infusion (Gammagard) | 3,868 | $36 | $108 |
| Denosumab injection (Prolia/Xgeva) | 2,580 | $19 | $51 |
| Complete blood count (CBC) with differential | 1,741 | $8 | $29 |
| Iron infusion (Monoferric) | 1,700 | $17 | $57 |
| Blood draw (venipuncture) | 1,672 | $8 | $9 |
| Office visit, established patient (30-39 min) | 1,227 | $99 | $339 |
| Dexamethasone injection (steroid) | 925 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 540 | $1 | $28 |
| Drug injection, under skin or into muscle | 419 | $11 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 288 | $0 | $9 |
| Administration of chemotherapy into vein, 1 hour or less | 250 | $104 | $378 |
| Office visit, established patient (20-29 min) | 247 | $67 | $239 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 217 | $50 | $189 |
| Injection of additional new drug or substance into vein | 178 | $12 | $61 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 166 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 143 | $23 | $84 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 124 | $16 | $56 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 110 | $1,163 | $3,717 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 109 | $401 | $680 |
| Administration of chemotherapy into vein, each additional hour | 104 | $23 | $79 |
| Injection, diphenhydramine hcl, up to 50 mg | 102 | $1 | $3 |
| CT scan of abdomen and pelvis with contrast | 92 | $181 | $557 |
| Ct scan of chest with contrast | 88 | $50 | $349 |
| Red blood count automated, with additional calculations | 78 | $5 | $20 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 72 | $134 | $562 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 57 | $56 | $206 |
| New patient office visit (45-59 min) | 56 | $129 | $453 |
| Infusion into a vein for hydration, each additional hour | 55 | $10 | $42 |
| Administration of additional new drug or substance into vein, 1 hour or less | 55 | $52 | $178 |
| Infusion, normal saline solution , 1000 cc | 46 | $2 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 38 | $25 | $156 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 31 | $3 | $11 |
| Automated urinalysis | 30 | $2 | $8 |
| Hospital follow-up visit, moderate complexity | 30 | $61 | $197 |
| CT scan of chest, without contrast | 27 | $60 | $362 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 26 | $25 | $89 |
| Initial hospital admission, high complexity | 25 | $136 | $556 |
| Echocardiogram, transthoracic | 22 | $99 | $440 |
| Injection of drug or substance into vein | 21 | $28 | $156 |
| Office visit, established patient, complex (40-54 min) | 16 | $145 | $474 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
25.5% high complexity
67.0% medium
7.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$27,923
Total received (2018-2024)
Avg $3,989/year across 7 years
Top 19% in FL for medical oncology
100
Companies
995
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,377 (62.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,001 (17.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,683 (16.8%)
Other
Charitable contributions, space rental, and other categories
$862 (3.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,491
2023
$4,716
2022
$3,730
2021
$4,013
2020
$6,562
2019
$3,680
2018
$731
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,988
Exelixis Inc.
$3,888
Ipsen Biopharmaceuticals, Inc
$2,285
Janssen Biotech, Inc.
$1,469
Novartis Pharmaceuticals Corporation
$1,369
PFIZER INC.
$1,088
Celgene Corporation
$951
GENZYME CORPORATION
$789
E.R. Squibb & Sons, L.L.C.
$771
Seagen Inc.
$642
Merck Sharp & Dohme LLC
$592
GlaxoSmithKline, LLC.
$507
Amgen Inc.
$493
Daiichi Sankyo Inc.
$453
Genentech USA, Inc.
$434
Astellas Pharma US Inc
$404
ABBVIE INC.
$383
Takeda Pharmaceuticals U.S.A., Inc.
$376
Sirtex Medical Inc
$288
NOVARTIS PHARMACEUTICALS CORPORATION
$283
Bayer HealthCare Pharmaceuticals Inc.
$271
Pharmacyclics LLC, An AbbVie Company
$264
Eisai Inc.
$251
ARRAY BIOPHARMA INC
$207
Incyte Corporation
$202
EMD Serono, Inc.
$201
BeiGene USA, Inc.
$200
Lilly USA, LLC
$196
Foundation Medicine, Inc.
$189
Rigel Pharmaceuticals, Inc.
$187
Alexion Pharmaceuticals, Inc.
$180
JAZZ PHARMACEUTICALS INC.
$168
Bayer Healthcare Pharmaceuticals Inc.
$168
Merck Sharp & Dohme Corporation
$146
SOBI, INC
$139
TerSera Therapeutics LLC
$139
Intuitive Surgical, Inc.
$131
Progenics Pharmaceuticals, Inc.
$127
Seattle Genetics, Inc.
$124
AVEO Pharmaceuticals, Inc.
$123
EISAI INC.
$118
Dova Pharmaceuticals
$109
Gilead Sciences, Inc.
$108
Deciphera Pharmaceuticals Inc.
$103
Shire North American Group Inc
$97
Boehringer Ingelheim Pharmaceuticals, Inc.
$97
Mirati Therapeutics, Inc.
$93
Regeneron Healthcare Solutions, Inc.
$90
Kite Pharma, Inc.
$87
Taiho Oncology, Inc.
$85
SANOFI-AVENTIS U.S. LLC
$85
AbbVie Inc.
$82
Adaptive Biotechnologies Corporation
$80
Dendreon Pharmaceuticals LLC
$74
THD America, Inc.
$73
MorphoSys, US Inc.
$73
Pharmacyclics LLC, an AbbVie Company
$70
Shield Therapeutics Inc
$70
Karyopharm Therapeutics Inc.
$67
Puma Biotechnology, Inc.
$64
Blueprint Medicines Corporation
$62
Sobi, Inc
$58
Kyowa Kirin, Inc.
$54
Tempus AI, Inc
$43
Clovis Oncology, Inc.
$43
Aurobindo Pharma USA, Inc.
$42
SUN PHARMACEUTICAL INDUSTRIES INC.
$41
CTI BioPharma Corp.
$41
Stemline Therapeutics Inc.
$40
Octapharma USA, Inc.
$40
PharmaEssentia USA Corporation
$39
Acceleron Pharma, Inc.
$38
TG THERAPEUTICS, INC.
$35
Genmab U.S., Inc.
$34
SHIELD THERAPEUTICS INC
$32
Myriad Genetic Laboratories, Inc.
$31
Aveo Pharmaceuticals, Inc.
$30
Fennec Pharmaceuticals, Inc.
$30
SERVIER PHARMACEUTICALS LLC
$26
EUSA Pharma (US) LLC
$25
TAIHO ONCOLOGY, INC.
$23
Heron Therapeutics, Inc.
$23
G1 Therapeutics, Inc.
$22
Legend Biotech USA Inc.
$22
Pharmacosmos Therapeutics Inc.
$22
Immunocore Limited
$20
Emmaus Medical, Inc.
$20
TESARO, Inc.
$18
TOLMAR Pharmaceuticals, Inc.
$18
Sun Pharmaceutical Industries Inc.
$17
Acrotech Biopharma Inc.
$17
RECORDATI_RARE_DISEASES_INC.
$17
SpringWorks Therapeutics, Inc.
$17
Teva Pharmaceuticals USA, Inc.
$16
Agios Pharmaceuticals, Inc.
$15
Acrotech Biopharma LLC
$14
Innate Pharma, Inc
$14
Verastem, Inc.
$13
Apellis Pharmaceuticals, Inc.
$12
Veracyte, Inc.
$5
Top 3 companies account for 36.4% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADAKVEO · ADCETRIS · ADVATE · AFINITOR · ALIMTA · ALUNBRIG · ASPARLAS · AUGTYRO · AYVAKIT · Abraxane · Aliqopa · Aranesp · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELELYSO · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · Empaveli · Endari · Enhertu · Epkinly · Erleada · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE LIQUID CDX · FRUZAQLA · Folotyn · GAMMAGARD · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Gazyva · HYQVIA · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · Jivi · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lumoxiti · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Odomzo · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Padcev · Pedmark · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · Quzyttir · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYLVANT · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TECENTRIQ · TECVAYLI · TEPMETKO · TEVIMBRA · TIVDAK · TUKYSA · Tecentriq · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VPRIV · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · Zoladex · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $39 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
21
Per 100K population
1.4
County median income
$81,115
Nearest hospital
GOOD SAMARITAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Berman is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 19% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Berman experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Berman performed 12,240 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Berman receive payments from pharmaceutical companies?
Yes. Dr. Berman received a total of $27,923 from 100 companies across 995 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berman's costs compare to other medical oncologists in West Palm Beach?
Dr. Berman's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in West Palm Beach
Browse medical oncologists in West Palm Beach ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Exelixis Inc. Payments to Doctors
See all physicians who received payments from Exelixis Inc.
By company
Ipsen Biopharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Ipsen Biopharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology